Navigation Links
Genzyme Corp. Signs Consent Decree to Correct Violations at Allston, Mass., Manufacturing Plant and Give up $175 Million in Profits
Date:5/24/2010

sorders. During an inspection of the Allston plant from Oct. 8, 2009, until Nov. 13, 2009, FDA inspectors found that the company's systems for ensuring manufacturing quality were inadequate resulting in production delays, critical shortages of medically necessary products to consumers and drugs contaminated with metal, fiber, rubber and glass particles. These manufacturing problems violated the FDA's regulations for manufacturing practice. Genzyme also temporarily suspended manufacturing of some products due to a viral contamination in a bioreactor that makes bulk amounts of its drugs. This resulted in additional drug shortages.

"It is critical for the safety of the drug supply that companies comply with basic manufacturing standards. FDA takes these obligations very seriously and expects manufacturers to do the same," said Joshua Sharfstein, M.D., FDA principal deputy commissioner.

Cerezyme, Fabrazyme, Myozyme, and Thyrogen are drug products that undergo all or some stages of manufacture at the Allston plant. Cerezyme treats Gaucher's disease, which causes fatty substances to accumulate in the liver, spleen and other organs. Fabrazyme treats Fabry disease, which prevents the body from breaking down oils and fats that build up in the eyes and the kidneys. Myozyme treats Pompe disease, a muscular disorder, and Thyrogen is used to diagnose thyroid cancer.

Genzyme has agreed to a work plan for making facility improvements. It begins with selecting, within 10 days of entry of the decree by the court, an independent expert who will inspect the plant and issue recommendations. Genzyme will use the expert's recommendations to create a work plan, subject to FDA approval, that requires specific steps for bringing its '/>"/>

SOURCE U.S. Food and Drug Administration
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Genzyme Announces Second Pivotal Mozobil Trial Meets Primary Endpoint
2. Genzyme and Bayer Schering Pharma AG, Germany Announce Start of Phase 3 Program with Alemtuzumab for Treatment of Multiple Sclerosis
3. Genzyme Completes Enrollment in Pivotal, Phase 2 Clinical Trial of Clofarabine in Adult AML
4. Genzyme Corporation Selects Diplomat Specialty Pharmacy for 2008 Renagel Medicare Part D Assistance Program
5. Genzyme Announces Presentation of New Positive Data on Carticel(R)
6. Genzyme Genetics Announces Launch of Carrier Testing and Prenatal Diagnosis for Spinal Muscular Atrophy
7. Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients
8. Genzyme and Isis Complete Licensing of Mipomersen
9. Genzyme and Isis Begin Second Phase 3 Trial Of Mipomersen
10. Pain Relief in Just One Visit with Genzymes Synvisc-One
11. Webcast Alert: Isis Pharmaceuticals and Genzyme Corporation to Present Mipomersen Phase 3 Data in HoFH During AHA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... N.J. , May 22, 2013 MEDIFIRST ... opportunity to update shareholders about some recent company developments. ... expand its avenues of communication with shareholders. Integrating social ... launched a Facebook page and will post updates on ... Twitter hashtag is #medifirstusa. Says CEO ...
(Date:5/22/2013)... Ranbaxy Laboratories Limited (hereafter, Ranbaxy), a ... Sankyo), announced on May 22 the actions that ... past conduct under prior management ... continues to support Ranbaxy in its efforts to ... which led to the investigations by the U.S. ...
(Date:5/22/2013)... and REHOVOT, Israel , May 22, ... ), a leading developer and provider of microRNA-based molecular ... , President and Chief Executive Officer of Rosetta Genomics, ... Healthcare Conference taking place from June 3-6, 2013 in ... on Tuesday, June 4 th at 2:00 p.m. ...
Breaking Medicine Technology:Medifirst Solutions, Inc. Announces Update To Shareholders 2Rosetta Genomics to Present at the Jefferies 2013 Healthcare Conference 2Rosetta Genomics to Present at the Jefferies 2013 Healthcare Conference 3
(Date:5/23/2013)... GBI Research’s analysis indicates that the global critical care ... of players accounting for a major proportion of the overall ... between 2006 and 2012, possibly due to the lack of ... in the US. , GBI Research estimates that the ... 2012, having grown in size at a CAGR of 11% ...
(Date:5/22/2013)... 2013 MileageAds.com, an American based full ... companies in the Stocks and Bonds Sector to display ... advertise with MileageAds will have the opportunity to take ... Stocks and bonds companies who accept Mileageads.com’s invitation will ... a specific, targeted audience on the internet ...
(Date:5/22/2013)... Boston, Mass, May 23, 2013 Existing research shows that ... risk of brain injury, but researchers at Boston Children,s ... place showed a 20 percent decrease in deaths and ... in bicycle-motor vehicle collisions. , The cross-sectional study, ... Lee, MD, MPH, Rebekah C. Mannix, MD, MPH of ...
(Date:5/22/2013)... The Yoga of Lady Niguma was created by a ... This is the oldest yoga found in written form (in ... the partner of renowned Indian master and yogi Naropa, and the ... a female yoga master. , Lady Niguma taught the practice ... through a long lineage to the second Dalai Lama, Gendun Gyatso. ...
(Date:5/22/2013)... May 22, 2013 A new study published ... found that of young people who visited fast food or ... who were obese were more likely to use calorie information ... also found that young people eating at fast food or ... likely to use calorie information as those eating there once ...
Breaking Medicine News(10 mins):Health News:MarketResearch.com Report – Increased Cost of Albumin was Main Factor for Double-Digit Growth of Global Critical Care Market Between 2006 and 2012 2Health News:Mileageads.com Ad Network Now Invites Companies in Stocks and Bonds Services Sector to Advertise on Their Ad Network 2Health News:Rate of bicycle-related fatalities significantly lower in states with helmet laws 2Health News:Popular Yoga DVD, Lady Niguma Yoga Released for Sale Online 2Health News:Popular Yoga DVD, Lady Niguma Yoga Released for Sale Online 3Health News:STRICTLY EMBARGOED UNTIL 6:00AM EST THURSDAY May 23, 2013; Calorie Information in Fast Food Restaurants Used by 40% of 9-18 Year Olds when Making Food Choices, Study Finds 2Health News:STRICTLY EMBARGOED UNTIL 6:00AM EST THURSDAY May 23, 2013; Calorie Information in Fast Food Restaurants Used by 40% of 9-18 Year Olds when Making Food Choices, Study Finds 3
... HealthDay Reporter , WEDNESDAY, March 16 (HealthDay News) ... to show a benefit for women with a rare lung ... a treatment. The drug, sirolimus (Rapamycin), improved both lung ... or LAM, according to a study published online March 16 ...
... -- On March 28, leading experts across multiple disciplines ... Therapies for Type 2 Diabetes to review the latest ... three-day meeting, hosted by NewYork-Presbyterian Hospital/Weill Cornell Medical Center ... and policymakers representing 60 countries. The Congress director is ...
... Carolina State University shows that while the number of visits ... for park operations has been significantly reduced. The reduction in ... than $20 billion in economic impact that state parks have ... support for operations puts stress on America,s state-park systems," says ...
... follow-up care for depression effectively and efficiently, according to ... that the Journal of General Internal Medicine ... months, compared to the half of the patients randomly ... three online care management contacts with a trained psychiatric ...
... loss and sleep disorders to health problems such as ... latest findings in sleep research will be presented and ... when the SLEEP 2011 25th Anniversary Meeting of the ... Convention Center from June 13 to 15. ...
... -- Newly proposed national standards for mercury, arsenic and ... as many as 17,000 premature deaths and 11,000 heart ... Agency. The proposed standards, released Wednesday by the ... prevent 120,000 cases of childhood asthma symptoms and 11,000 ...
Cached Medicine News:Health News:Transplant Drug May Fight Rare Lung Disorder 2Health News:Transplant Drug May Fight Rare Lung Disorder 3Health News:Diabetes Surgery 2nd World Congress 2Health News:Diabetes Surgery 2nd World Congress 3Health News:Diabetes Surgery 2nd World Congress 4Health News:Diabetes Surgery 2nd World Congress 5Health News:Study shows attendance at state parks grows, even as funding decreases 2Health News:Online messaging delivers follow-up care for depression 2Health News:EPA Proposes Tougher Air Pollution Rules for Power Plants 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: